Abbott Laboratories (Pakistan) (KAR:ABOT) E10: ₨48.67 (As of Mar. 2026)


KAR:ABOT Abbott Laboratories (Pakistan) Ltd KAR:ABOT
77 GF Score
Price ₨966.44
GF Value ₨1,001.38
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Abbott Laboratories (Pakistan) E10?

Abbott Laboratories (Pakistan) KAR:ABOT 77 E10 is ₨48.67 as of Mar. 2026. GuruFocus rates KAR:ABOT with a GF Score™ of 77/100 and a GF Value™ of ₨1,001.38 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Abbott Laboratories (Pakistan)'s adjusted earnings per share data for the three months ended in Mar. 2026 was ₨19.820. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₨48.67 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Abbott Laboratories (Pakistan)'s average E10 Growth Rate was 10.80% per year. During the past 3 years, the average E10 Growth Rate was 4.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Abbott Laboratories (Pakistan) was 4.00% per year. The lowest was 4.00% per year. And the median was 4.00% per year.

As of today (2026-06-28), Abbott Laboratories (Pakistan)'s current stock price is ₨966.44. Abbott Laboratories (Pakistan)'s E10 for the quarter that ended in Mar. 2026 was ₨48.67. Abbott Laboratories (Pakistan)'s Shiller PE Ratio of today is 19.86.

During the past 13 years, the highest Shiller PE Ratio of Abbott Laboratories (Pakistan) was 30.15. The lowest was 8.38. And the median was 16.70.


Abbott Laboratories (Pakistan)  (KAR:ABOT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Abbott Laboratories (Pakistan)'s Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=966.44/48.67
=19.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Abbott Laboratories (Pakistan) was 30.15. The lowest was 8.38. And the median was 16.70.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Abbott Laboratories (Pakistan) E10 Related Terms


Abbott Laboratories (Pakistan) E10 Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories (Pakistan)'s E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories (Pakistan) E10 Chart

Abbott Laboratories (Pakistan) Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 41.58 39.84 42.52 46.82

Abbott Laboratories (Pakistan) Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.94 45.05 45.91 46.82 48.67

KAR:ABOT vs ZTS, UTHR, VTRS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Abbott Laboratories (Pakistan)'s Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories (Pakistan) Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott Laboratories (Pakistan)'s Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories (Pakistan)'s Shiller PE Ratio falls into.


KAR:ABOT
77GF Score
Abbott Laboratories (Pakistan) Ltd KAR:ABOT
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories (Pakistan) E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abbott Laboratories (Pakistan)'s adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=19.82/330.2130*330.2130
=19.820

Current CPI (Mar. 2026) = 330.2130.

Abbott Laboratories (Pakistan) Quarterly Data

per share eps CPI Adj_EPS
201606 10.000 241.018 13.701
201609 11.690 241.428 15.989
201612 12.010 241.432 16.426
201703 7.200 243.801 9.752
201706 9.940 244.955 13.400
201709 11.350 246.819 15.185
201712 14.460 246.524 19.369
201803 6.340 249.554 8.389
201806 6.460 251.989 8.465
201809 8.350 252.439 10.923
201812 6.370 251.233 8.373
201903 3.350 254.202 4.352
201906 1.830 256.143 2.359
201909 2.710 256.759 3.485
201912 5.390 256.974 6.926
202003 8.810 258.115 11.271
202006 12.850 257.797 16.460
202009 10.070 260.280 12.776
202012 14.610 260.474 18.522
202103 14.730 264.877 18.363
202106 18.790 271.696 22.837
202109 12.360 274.310 14.879
202112 15.070 278.802 17.849
202203 14.730 287.504 16.918
202206 3.450 296.311 3.845
202209 8.020 296.808 8.923
202212 4.490 296.797 4.996
202303 -2.240 301.836 -2.451
202306 -5.930 305.109 -6.418
202309 0.070 307.789 0.075
202312 10.770 306.746 11.594
202403 15.510 312.332 16.398
202406 6.350 314.175 6.674
202409 18.480 315.301 19.354
202412 13.120 315.605 13.727
202503 16.340 319.799 16.872
202506 19.850 322.561 20.321
202509 18.620 324.800 18.930
202512 26.560 324.054 27.065
202603 19.820 330.213 19.820

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₨48.67 mean?
Abbott Laboratories (Pakistan) (KAR:ABOT) has a E10 of ₨48.67 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Abbott Laboratories (Pakistan) and its competitors.
Is Abbott Laboratories (Pakistan)'s E10 too high?
Abbott Laboratories (Pakistan)'s current E10 is ₨48.67. Overall, Abbott Laboratories (Pakistan) has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories (Pakistan)'s E10 compare to ZTS and UTHR?
Abbott Laboratories (Pakistan)'s E10 of ₨48.67 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Abbott Laboratories (Pakistan) and its competitors. Abbott Laboratories (Pakistan)'s current E10 is ₨48.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories (Pakistan) stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) (KAR:ABOT) is currently considered Fairly Valued. The stock's GF Value™ is ₨1,001.38, compared to a current price of ₨966.44 — trading 3.5% below its estimated fair value. The current E10 is ₨48.67. Abbott Laboratories (Pakistan)'s overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Abbott Laboratories (Pakistan) (KAR:ABOT), the current E10 is ₨48.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (Pakistan) (KAR:ABOT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories (Pakistan) stock appears to be undervalued. The current stock price of ₨966.44 is trading 3.5% below its estimated GF Value™ of ₨1,001.38. GuruFocus considers Abbott Laboratories (Pakistan) to be Fairly Valued.

Key valuation signals for KAR:ABOT:

  • E10: ₨48.67
  • GF Value™: ₨1,001.38 vs. price of ₨966.44 (3.5% below fair value)
  • GF Score™: 77/100 with 2 warning signs

No single metric tells the full story. See the KAR:ABOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Abbott Laboratories (Pakistan) Business Description

Address Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120
Abbott Laboratories (Pakistan) Ltd manufactures, imports, and markets research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. The company's Brands include Duphaston, Brufen, Surbex Z, Arinac, Glucerna, Pediasure, and Ensure.
77GF Score

Get the complete analysis for KAR:ABOT

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨966.44
Price
₨1,001.38
GF Value